Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by porksnifferon Aug 19, 2021 6:55pm
105 Views
Post# 33737561

RE:RE:4 Year Shorting Hammer

RE:RE:4 Year Shorting HammerYou are delusional if you think the same '300 die hards' are still invested here because you heard it at an annual meeting 3 years ago. It is laughable to think professional investors are going to hang around while absorbing 3 years of losses without so much as a dividend at least. 

The stock has been churning for over a year, higher volume drifting down in price. This means selling (distribution) not by retail pikers (like yourself) but big holders. No one is pushing up the price, the selling pushes it down. The only thing propping this turd up is buybacks...with shareholder money. You can go ahead and think what you want this will be taken private for a tiny premium after as many shares are cancelled as possible. 
<< Previous
Bullboard Posts
Next >>